Michael Tompkins

Michael Tompkins has a diverse work experience spanning multiple industries. Michael currently holds the position of Director of Business Development and Facility Operations at ProScan Imaging since April 2022. Prior to that, they worked as a Senior Territory Sales Manager at Urovant Sciences, Inc. from January 2021 to March 2022. From February 2020 to November 2020, they served as a Corporate Account Manager at Dendreon, and from July 2018 to February 2020, they worked as an Immunotherapy Territory Manager at the same company.

Before joining Dendreon, Tompkins worked as a Business Development Executive at Stratpharma from February 2017 to July 2018. Michael'sresponsibilities included working collaboratively with regional business managers and clinical wound care specialists, managing global distribution partners, and maintaining key relationships with healthcare institutions such as Memorial Sloan Kettering Cancer Center, MD Anderson, 21st Century Oncology, and Baptist Miami.

From March 2009 to July 2015, they held the position of Director of Ancillary Services at 21st Century Oncology, where they were responsible for implementing and executing various non-radiation medical practices, including CT, MRI, PET/CT, and Laboratory Medicine. Michael also worked on special projects such as ePrescribe, Provenge and Xofigo launch, surgery center management, and chemotherapy infusion pharmacy development.

Prior to their role at 21st Century Oncology, Tompkins worked as the Director of Oncology Sales at Triad Isotopes from 2007 to 2009. Michael began their career at MedTech Diagnostics as a Sales Manager from January 2001 to September 2007. Michael also worked as an Account Manager at Becton Dickson in 1995.

Michael Tompkins earned a Bachelor of Science degree in Microbiology Biochemistry from an undisclosed institution between the years 1986 and 1990.